Impact Factor 2023

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2596

PDF: 1350
New approved drugs for psoriatic arthritis

F.M. Perrotta, E. Lubrano

57-64

09-09-2016

https://doi.org/10.4081/reumatismo.2016.873

3043

PDF: 2177
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

143-166

31-10-2013

https://doi.org/10.4081/reumatismo.2013.143

6992

PDF: 2496
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini

45-56

16-09-2015

https://doi.org/10.4081/reumatismo.2015.811

2116

PDF: 1062
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2283

PDF: 1537
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2536

PDF: 1193
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

54-64

https://doi.org/10.4081/reumatismo.2009.54

1223

PDF: 1025
Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

57-61

16-09-2015

https://doi.org/10.4081/reumatismo.2015.823

2138

PDF: 1017
How much does an antiinflammatory treatment cost?

D. Gatti, O. Viapiana, G. Colombo, S. Adami

248-252

https://doi.org/10.4081/reumatismo.2010.248

1227

PDF: 642
Safety of lornoxicam in G-6-PDH deficiency

G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero

45-47

https://doi.org/10.4081/reumatismo.2003.45

749

PDF: 544
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1602

1753

PDF: 417
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

07-04-2025

https://doi.org/10.4081/reumatismo.2025.1817

388

PDF: 149

SUPPLEMENTARY MATERIAL: 70
Italian Society of Rheumatology recommendations for the management of gout

M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

4-21

28-03-2013

https://doi.org/10.4081/reumatismo.2013.4

5650

PDF: 1503
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

29-01-2025

https://doi.org/10.4081/reumatismo.2025.1754

867

PDF: 242

SUPPLEMENTARY MATERIAL: 81
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

285-303

31-03-2015

https://doi.org/10.4081/reumatismo.2014.799

2466

PDF: 2237
Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

224-235

https://doi.org/10.4081/reumatismo.2003.224

1093

PDF: 2480
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

32-37

https://doi.org/10.4081/reumatismo.2007.32

1612

PDF: 730
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1149

PDF: 764
The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

L. Riente

74-79

https://doi.org/10.4081/reumatismo.2004.1s.74

736

PDF: 880
Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

46-50

https://doi.org/10.4081/reumatismo.2010.46

1080

PDF: 1298
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

620

PDF: 548
Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

145-150

https://doi.org/10.4081/reumatismo.2001.145

978

PDF: 696
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease

Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

22-01-2025

https://doi.org/10.4081/reumatismo.2025.1744

766

PDF: 163

SUPPLEMENTARY MATERIAL: 78
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

299-303

https://doi.org/10.4081/reumatismo.2007.299

894

PDF: 705
Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases

R. Deniz, N. Güner, Ş.A. Ekmen, İ.N. Mutlu, D.S. Özgür, B. Karaalioğlu, G. Akkuzu, F. Yıldırım, K. Kalkan, G. Güzelant-Özköse, B. İnce, M. Erdoğan, Y. Özlük, I. Kılıçaslan, C. Bes

18-09-2023

https://doi.org/10.4081/reumatismo.2023.1586

1211

PDF: 497
Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

M. Arreghini, P. Prudente, W. Maglione, C. Arnoldi, S. Tosi, A. Marchesoni

140-144

https://doi.org/10.4081/reumatismo.2001.140

797

PDF: 1133
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

244-261

https://doi.org/10.4081/reumatismo.2007.244

1282

PDF: 1095
Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

104-109

https://doi.org/10.4081/reumatismo.2004.104

1205

PDF: 1002
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

34-39

https://doi.org/10.4081/reumatismo.2005.4s.34

1119

PDF: 1107
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3692

PDF: 2382
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

29-12-2022

https://doi.org/10.4081/reumatismo.2022.1511

1798

PDF: 760
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

M.G. Portuesi, P. Perosa

61-63

https://doi.org/10.4081/reumatismo.2008.61

1140

PDF: 853
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

93-102

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1235

873

PDF: 556
Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren’s syndrome (SS) not responding to standard treatment with artificial tears

P. Ostuni, M.E.C. Battista, A. Furlan

119-124

https://doi.org/10.4081/reumatismo.2005.119

954

PDF: 2003
Safety of rituximab in rheumatoid arthritis

M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

101-106

https://doi.org/10.4081/reumatismo.2010.101

1635

PDF: 978
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1608

1408

PDF: 514
The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis

S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè

22-49

23-09-2019

https://doi.org/10.4081/reumatismo.2019.1202

7763

PDF: 2304
A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib

F.M. Mariani, A. Alunno, F. Carubbi, C. Ferri

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1620

1306

PDF: 442
TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

275-282

https://doi.org/10.4081/reumatismo.2006.275

1006

PDF: 917
Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis

G.P. Pasero, O. Di Munno

238-242

https://doi.org/10.4081/reumatismo.2002.238

3773
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

28-10-2024

https://doi.org/10.4081/reumatismo.2024.1796

1385

PDF: 163
IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

62-73

https://doi.org/10.4081/reumatismo.2004.1s.62

1249

PDF: 1890
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

268-274

https://doi.org/10.4081/reumatismo.2006.268

1520

PDF: 2647
The treatment of recurrent uveitis with TNFα inhibitors

P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

185-189

https://doi.org/10.4081/reumatismo.2004.185

1718

PDF: 2338
Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis

K.V. Ilic, M. Sefik-Bukilica, S. Jankovic, N. Vujasinovic-Stupar

27-33

https://doi.org/10.4081/reumatismo.2009.27

1463

PDF: 1094
Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

261-267

https://doi.org/10.4081/reumatismo.2006.261

1171

PDF: 680
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

290-295

https://doi.org/10.4081/reumatismo.2008.290

2037

PDF: 1049
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis

I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia

21-03-2023

https://doi.org/10.4081/reumatismo.2022.1528

917

PDF: 532
Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

209-214

https://doi.org/10.4081/reumatismo.2007.209

882

PDF: 1009
Treatment of Wegener’s granulomatosis

V. Riccieri, G. Valesini

69-76

https://doi.org/10.4081/reumatismo.2004.69

1308

PDF: 5051

1 - 50 of 54 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy